Agilent

Executive Summary

Agilent is a global leader in life sciences, diagnostics, and applied chemical markets, providing comprehensive scientific solutions including instruments, software, and services. The company serves customers across academia, government, and industry, enabling reliable answers and superior outcomes. With a valuation of approximately $32.7 billion and a strong presence in Belgium, Agilent continues to innovate and expand its portfolio. The company's focus on proteomics, genetics, and genomics positions it well for growth in precision medicine and biopharmaceutical development. Despite being private, Agilent maintains a robust market position and is expected to benefit from ongoing investments in R&D and strategic collaborations.

Upcoming Catalysts (preview)

• Q3 2026Launch of Next-Generation Mass Spectrometry Platform55% success
• Q4 2026Strategic Partnership in Diagnostics with Major Pharma50% success
• Q1 2027Acquisition of a Bioinformatics Startup45% success